TEMPORAL TRENDS IN THE HOSPITAL BURDEN OF ATRIAL FIBRILLATION AND STROKE ON SECONDARY CARE COSTS IN ENGLAND BETWEEN 2006 AND 2009

Author(s)

Bakhai A1, Righetti C2, Punekar Y2, Majeed A31AMORE Health Ltd, London, United Kingdom, 2Sanofi-aventis, Surrey, United Kingdom, 3Imperial College, London, United Kingdom

OBJECTIVES: Atrial fibrillation (AF) is the commonest cardiac arrhythmia found in clinical practice with an increasing prevalence in the aging population. Local estimates vary from 1.2 to 2.5%. The objective of our study was to evaluate the burden of AF on secondary care costs in England, which is responsible for substantial cardiovascular morbidity and mortality. METHODS: AF and stroke event and cost data captured in Hospital Episode Statistics(HES), between 2006 and 2009, was analysed to estimate the trends in hospital episodes in England. RESULTS: A total of 193,742 patients with a primary or secondary diagnosis of AF were hospitalised in 2009, representing a 19% increase in AF patients on the previous 3 years. During this period there were 239,746 hospital spells with a diagnosis of AF; a 22% increase from 2006-2009. The total inpatient cost attributable to AF increased from £353 million in 2006 to a total of £361 million in 2009. As a proportion of all admissions, AF admissions were 1.1% in 2006 to 1.2% in 2009 and represented 1,162,213 bed days occupied in 2006 versus 1,108,283 in 2009. In 2009, of the 193,742 patients with a diagnosis of AF, 5,391 subsequently had a stroke. This gives a conversion rate from AF to stroke of 3.1% of patients – up from 2.5% in 2006. During this same period, the average length of stay for the stroke patient with AF has increased from 38 days to 43 days (higher than those patients who have only had a stroke). CONCLUSIONS: Despite advances in both AF and stroke management, AF presents a significant and increasing burden on hospital care in England. New initiatives are needed to detect AF early and prevent hospital admissions or to manage AF in rapid access arrhythmia clinics where appropriate therapies to manage the rate, rhythm and cardiovascular risks can be dispensed without needing admission.

Conference/Value in Health Info

2011-11, ISPOR Europe 2011, Madrid, Spain

Value in Health, Vol. 14, No. 7 (November 2011)

Code

PCV52

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×